A discussion between our CEO + University of Oxford’s Sarah Gilbert | Ferrovial
Our CEO, Ignacio Madridejos, sat down with Sarah Gilbert, one of the researchers who is leading the development of the COVID-19 vaccine at the University of Oxford. They discussed the vaccine in-depth and how our donation of €500,000 is helping them in their research. This donation was part of our #FerrovialTogetherCOVID19 fund.
- GUtech and COBOD set 3D printing of buildings world recordDigital Construction
- Kier Group MD to leave by end of 2022, replacement confirmedConstruction Projects
- Liberty reaches agreement in principle for debt restructureConstruction Projects
- KSA invites prequalification bids for Makkah TOD projectConstruction Projects